Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation

ConditionTriglycerides
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-59
SponsorMedinutra LLC

About this trial

Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of either Longvida Curcumin, astaxanthin, or a placebo. A few side blood analysis will also be done. These measures are relevant to low level inflammation.

Eligibility criteria

Qualifiers

Triglyceride reading of 140-250 mg/dL

Age 21-59

Disqualifiers

Uncontrolled diabetes

Hypothyroidism or other hormonal problems that have not stabilized

Any liver diseases being actively treated

Cancer

Trial design

Treatments tested in this trial

  • Curcumin (Longvida™)
  • Half Dose Curcumin (Longvida™)
  • Astaxanthin
  • Placebo Control

Treatment groups

64 Participants
are divided into 4 treatment groups

Sponsors and collaborators